Adjunctive oral methylprednisolone in pediatric acute pyelonephritis alleviates renal scarring

Pediatrics

Volumn 128, Issue 3, 2011, Pages

  Huang, Ya Yun ^a   Chen, Mei Ju ^b   Chiu, Nan Tsing ^a   Chou, Hsin Hsu ^c   Lin, Kuang Yen ^a   Chiou, Yuan Yow ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b CHUNG HWA UNIVERSITY OF MEDICAL TECHNOLOGY   (Taiwan)

^c CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

Acute pyelonephritis; Glucocorticoid; Pediatric; Renal scar

Indexed keywords

6ALPHA METHYLPREDNISOLONE 21 PHOSPHATE; CEFALOTIN; EXCELIN; GENTAMICIN; GLUCOCORTICOID; PLACEBO; SUCCIMER TC 99M; UNCLASSIFIED DRUG;

ACUTE PYELONEPHRITIS; ADJUVANT THERAPY; ADOLESCENT; ARTICLE; BLOOD CULTURE; CHILD; CHILD HOSPITALIZATION; CONTROLLED STUDY; DEFERVESCENCE; DISEASE COURSE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ECHOGRAPHY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HOSPITAL PATIENT; HUMAN; INFANT; KIDNEY CORTEX; KIDNEY SCAR; MAJOR CLINICAL STUDY; MALE; MICTURITION CYSTOURETHROGRAPHY; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SHORT COURSE THERAPY; TREATMENT DURATION; URINARY TRACT INFECTION;

ACUTE DISEASE; ADMINISTRATION, ORAL; ANTI-BACTERIAL AGENTS; CICATRIX; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; INFANT; INFANT, NEWBORN; MALE; METHYLPREDNISOLONE; MICROBIAL SENSITIVITY TESTS; MULTIVARIATE ANALYSIS; PYELONEPHRITIS; RISK FACTORS;

EID: 80052359881     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2010-0297     Document Type: Article

References (57)

1. Wennerström M., Hansson S., Jodal U., Stokland E. Primary and acquired renal scarring in boys and girls with urinary tract infection. J Pediatr. 2000;136(1):30-34 (Pubitemid 30468553)
2. Lin K.Y., Chiu N.T., Chen M.J., et al. Acute pyelonephritis and sequelae of renal scar in pediatric first febrile urinary tract infection. Pediatr Nephrol. 2003;18(4):362-365
3. Patzer L., Seeman T., Luck C., Wühl E., Janda J., Misselwitz J. Day- and night-time blood pressure elevation in children with higher grades of renal scarring. J Pediatr. 2003;142(2):117-122 (Pubitemid 36232898)
4. Soergel M., Kirschstein M., Busch C., et al. Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: A multicenter trial including 1141 subjects. J Pediatr. 1997;130(2):178-184 (Pubitemid 27495150)
5. Martinell J., Jodal U., Lidin-Janson G. Pregnancies in women with and without renal scarring after urinary infections in childhood. BMJ. 1990;300(6728):840-844 (Pubitemid 20113346)
6. Jacobson S.H., Eklöf O., Eriksson C.G., Lins L.E., Tidgren B., Winberg J. Development of hypertension and uraemia after pyelonephritis in childhood: 27 year follow up. BMJ. 1989;299(6701):703-706 (Pubitemid 19235914)
7. Sacks S.H., Verrier Jones K., Roberts R., Asscher A.W., Ledingham J.G. Effect of symptom-less bacteriuria in childhood on subsequent pregnancy. Lancet. 1987;2(8566):991-994 (Pubitemid 17150858)
8. Faust W.C., Diaz M., Pohl H.G. Incidence of postpyelonephritic renal scarring: A metaanalysis of the dimercapto-succinic acid literature. J Urol. 2009;181(1):290-297; discussion 297-298
9. Glauser M.P., Lyons J.M., Braude A.I. Prevention of chronic experimental pyelonephritis by suppression of acute suppuration. J Clin Invest. 1978;61(2):403-407 (Pubitemid 8280411)
10. Shimamura T. Mechanisms of renal tissue destruction in an experimental acute pyelonephritis. Exp Mol Pathol. 1981;34(1):34-42 (Pubitemid 11134207)
11. Glauser M.P., Meylan P., Bille J. The inflammatory response and tissue damage. The example of renal scars following acute renal infection. Pediatr Nephrol. 1987;1(4):615-622 (Pubitemid 18014579)
12. Matsumoto T., Haraoka M., Mizunoe Y., et al. Renal scarring is enhanced by phorbol myristate acetate following infection with bacteria with mannose-sensitive pili. Nephron. 1993;64(3):405-409 (Pubitemid 23202849)
13. Roberts J.A., Roth J.K. Jr, Domingue G., Lewis R.W., Kaack B., Baskin G. Immunology of pyelonephritis in the primate model. VI. Effect of complement depletion. J Urol. 1983;129(1):193-196 (Pubitemid 13148092)
14. Matsumoto T., Mitzunoe Y., Ogata N., Tanaka M., Takahashi K., Kumazawa J. Antioxidant effect on renal scarring following infection of mannose-sensitive-piliated bacteria. Nephron. 1992;60(2):210-215
15. Khalil A., Tullus K., Bakhiet M., Burman L.G., Jaremko G., Brauner A. Angiotensin II type 1 receptor antagonist (losartan) downregulates transforming growth factor-beta in experimental acute pyelonephritis. J Urol. 2000;164(1):186-191 (Pubitemid 30434298)
16. Sener G., Tuǧtepe H., Velioglu-Oǧunc A., Cetinel S., Gedik N., Yeǧen B.C. Melatonin prevents neutrophil-mediated oxidative injury in Escherichia coli-induced pyelonephritis in rats. J Pineal Res. 2006;41(3):220-227 (Pubitemid 44337717)
17. Biyikli NK, Tuǧtepe H, Sener G, et al. Oxytocin alleviates oxidative renal injury in pyelonephritic rats via a neutrophil-dependent mechanism. Peptides. 2006;27(9):2249-2257
18. Huang A., Palmer L.S., Hom D., Anderson A.E., Kushner L., Franco I. Ibuprofen combined with antibiotics suppresses renal scarring due to ascending pyelonephritis in rats. J Urol. 1999;162(4):1396-1398 (Pubitemid 29428603)
19. Mochida O., Matsumoto T., Mizunoe Y., Sakumoto M., Abe J., Kumazawa J. Preventive effect of dapsone on renal scarring following mannose-sensitive piliated bacterial infection. Chemotherapy. 1998;44(1):36-41 (Pubitemid 28009173)
20. Odio C.M., Faingezicht I., Paris M., et al. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med. 1991;324(22):1525-1531
21. Lebel M.H., Freij B.J., Syrogiannopoulos G.A., et al. Dexamethasone therapy for bacterial meningitis. Results of 2 double-blind, placebo-controlled trials. N Engl J Med. 1988;319(15):964-971
22. Mustafa M.M., Ramilo O., Sáez-Llorens X., Olsen K.D., Magness R.R., McCracken G.H. Jr. Cerebrospinal fluid prostaglandins, interleukin 1 beta, and tumor necrosis factor in bacterial meningitis. Clinical and laboratory correlations in placebo-treated and dexamethasone-treated patients. Am J Dis Child. 1990;144(8):883-887 (Pubitemid 20232954)
23. Schaad U.B., Lips U., Gnehm H.E., Blumberg A., Heinzer I., Wedgwood J. Dexamethasone therapy for bacterial meningitis in children. Swiss Meningitis Study Group. Lancet. 1993;342(8869):457-461 (Pubitemid 23240309)
24. Pohl H.G., Rushton H.G., Park J.S., Chandra R., Majd M. Adjunctive oral corticosteroids reduce renal scarring: The piglet model of reflux and acute experimental pyelonephritis. J Urol. 1999;162(3 pt 1):815-820 (Pubitemid 29436896)
25. Haraoka M., Matsumoto T., Takahashi K., Kubo S., Tanaka M., Kumazawa J. Suppression of renal scarring by prednisolone combined with ciprofloxacin in ascending pyelonephritis in rats. J Urol. 1994;151(4):1078-1080 (Pubitemid 24083518)
26. Haraoka M., Matsumoto T., Mizunoe Y., et al. Effect of prednisolone on renal scarring in rats following infection with Serratia marcescens. Ren Fail. 1993;15(5):567-571 (Pubitemid 23358553)
27. Sharifian M., Anvaripour N., Karimi A., et al. The role of dexamethasone on decreasing urinary cytokines in children with acute pyelonephritis. Pediatr Nephrol. 2008;23(9):1511-1516
28. Chiou Y.Y., Wang S.T., Tang M.J., Lee B.F., Chiu N.T. Renal fibrosis: prediction from acute pyelonephritis focus volume measured at 99mTc dimercaptosuccinic acid SPECT. Radiology. 2001;221(2):366-370
29. Wang Y.T., Chiu N.T., Chen M.J., Huang J.J., Chou H.H., Chiou Y.Y. Correlation of renal ultrasonographic findings with inflammatory volume from dimercaptosuccinic acid renal scans in children with acute pyelonephritis. J Urol. 2005;173(1):190-194
30. Jakobsson B., Svensson L. Transient pyelonephritic changes on 99mTechnetium-dimercaptosuccinic acid scan for at least five months after infection. Acta Paediatr. 1997;86(8):803-807 (Pubitemid 27342721)
31. Lebowitz R.L., Olbing H., Parkkulainen K.V., Smellie J.M., Tamminen-Möbius T.E. International system of radiographic grading of vesicoureteric reflux. International Reflux Study in Children. Pediatr Radiol. 1985;15(2):105-109 (Pubitemid 15198933)
32. Sheu J.N., Chen M.C., Cheng S.L., Lee I.C., Chen S.M., Tsay G.J. Urine interleukin-1beta in children with acute pyelonephritis and renal scarring. Nephrology (Carlton). 2007;12(5):487-493 (Pubitemid 47366638)
33. Sheu J.N., Chen S.M., Meng M.H., Lue K.H. The role of serum and urine interleukin-8 on acute pyelonephritis and subsequent renal scarring in children. Pediatr Infect Dis J. 2009;28(10):885-890
34. Yen T.C., Chen W.P., Chang S.L., Liu R.S., Yeh S.H., Lin C.Y. Technetium-99m-DMSA renal SPECT in diagnosing and monitoring pediatric acute pyelonephritis. J Nucl Med. 1996;37(8):1349-1353
35. Cheng C.H., Tsau Y.K., Kuo C.Y., Su L.H., Lin T.Y. Comparison of extended virulence genotypes for bacteria isolated from pediatric patients with urosepsis, acute pyelonephritis, and acute lobar nephronia. Pediatr Infect Dis J. 2010;29(8):736-740
36. Stark A.R., Carlo W.A., Tyson J.E., et al National Institute of Child Health and Human Development Neonatal Research Network. Adverse effects of early dexamethasone in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med. 2001;344(2):95-101
37. Barrington K.J. The adverse neurodevelopmental effects of postnatal steroids in the preterm infant: A systematic review of RCTs. BMC Pediatr. 2001;1:1
38. O'Shea T.M., Kothadia J.M., Klinepeter K.L., et al. Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: Outcome of study participants at 1-year adjusted age. Pediatrics. 1999;104(1 pt 1):15-21 (Pubitemid 29315841)
39. Shinwell E.S., Karplus M., Reich D., et al. Early postnatal dexamethasone treatment and increased incidence of cerebral palsy. Arch Dis Child Fetal Neonatal Ed. 2000;83(3):F177-F181
40. Scarfone R.J., Fuchs S.M., Nager A.L., Shane S.A. Controlled trial of oral prednisone in the emergency department treatment of children with acute asthma. Pediatrics. 1993;92(4):513-518 (Pubitemid 23286878)
41. Tibballs J., Shann F.A., Landau L.I. Placebo- controlled trial of prednisolone in children intubated for croup. Lancet. 1992;340(8822):745-748
42. Rubin B.K., Marcushamer S., Priel I., App E.M. Emergency management of the child with asthma. Pediatr Pulmonol. 1990;8(1):45-57
43. Corneli H.M., Zorc J.J., Mahajan P., et al. A multicenter, randomized, controlled trial of dexamethasone for bronchiolitis. N Engl J Med. 2007;357(4):331-339 (Pubitemid 47124133)
44. Swantek J.L., Cobb M.H., Geppert T.D. Jun N-terminal kinase/stress- activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: Glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK. Mol Cell Biol. 1997;17(11):6274-6282 (Pubitemid 27451171)
45. Lasa M., Brook M., Saklatvala J., Clark A.R. Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38. Mol Cell Biol. 2001;21(3):771-780 (Pubitemid 32104726)
46. Caelles C., González-Sancho J.M., Muñoz A. Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway. Genes Dev. 1997;11(24):3351-3364 (Pubitemid 28023959)
47. Almawi W.Y., Melemedjian O.K. Negative regulation of nuclear factor-kappaB activation and function by glucocorticoids. J Mol Endocrinol. 2002;28(2):69-78 (Pubitemid 34428757)
48. Moynagh P.N. Toll-like receptor signalling pathways as key targets for mediating the anti-inflammatory and immunosuppressive effects of glucocorticoids. J Endocrinol. 2003;179(2):139-144 (Pubitemid 37461343)
49. Wolfs T.G., Buurman W.A., Van Schadewijk A., et al. In vivo expression of Toll-like receptor 2 and 4 by renal epithelial cells: IFN-gamma and TNF-alpha mediated up-regulation during inflammation. J Immunol. 2002;168(3):1286-1293 (Pubitemid 34094497)
50. Shigeoka A.A., Holscher T.D., King A.J., et al. TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both MyD88-dependent and -independent pathways. J Immunol. 2007;178(10):6252- 6258 (Pubitemid 46717408)
51. Kim B.S., Lim S.W., Li C., et al. Ischemiareperfusion injury activates innate immunity in rat kidneys. Transplantation. 2005;79(10):1370-1377 (Pubitemid 40740256)
52. González M.V., González-Sancho J.M., Caelles C., Munoz A., Jiménez B. Hormone-activated nuclear receptors inhibit the stimulation of the JNK and ERK signalling pathways in endothelial cells. FEBS Lett. 1999;459(2):272-276 (Pubitemid 29475046)
53. Ito K., Barnes P.J., Adcock I.M. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12. Mol Cell Biol. 2000;20(18):6891-6903
54. Bhattacharyya S., Brown D.E., Brewer J.A., Vogt S.K., Muglia L.J. Macrophage glucocorticoid receptors regulate Toll-like receptor 4-mediated inflammatory responses by selective inhibition of p38 MAP kinase. Blood. 2007;109(10):4313-4319 (Pubitemid 46743398)
55. Meisler N., Shull S., Xie R., et al. Glucocorticoids coordinately regulate type I collagen pro alpha 1 promoter activity through both the glucocorticoid and transforming growth factor beta response elements: A novel mechanism of glucocorticoid regulation of eukaryotic genes. J Cell Biochem. 1995;59(3):376-388
56. Tuǧtepe H., Sener G., Cetinel S., Velioǧlu-Ogünc A., Yeǧen B.C. Oxidative renal damage in pyelonephritic rats is ameliorated by montelukast, a selective leukotriene CysLT1 receptor antagonist. Eur J Pharmacol. 2007;557(1):69-75 (Pubitemid 46156939)
57. Hiraoka M., Hashimoto G., Tsuchida S., Tsukahara H., Ohshima Y., Mayumi M. Early treatment of urinary infection prevents renal damage on cortical scintigraphy. Pediatr Nephrol. 2003;18(2):115-118 (Pubitemid 41490297)